AstraZeneca heart drug fails in key stroke trial

LONDON (Reuters) - AstraZeneca said on Wednesday its blood-thinning drug Brilinta failed to help stroke patients as hoped in a major clinical trial, dealing a blow to a product viewed as an important driver of future sales and profits.

http://ift.tt/1o5NiQ2

from Reuters: Health News
via animenewspro